✦ LIBER ✦

G.P.10.03 Therapeutic effects of ephedrine in congenital myasthenic syndrome due to DOK7 mutations

✍ Scribed by U. Schara; M. Deschauer; M. Wendt; N. Strigl-Pill; J. Müller; A. Abicht; H. Lochmüller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ephedrine therapy in eight patients with

✍ U. Schara; N. Barisic; M. Deschauer; C. Lindberg; V. Straub; N. Strigl-Pill; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

G.P.10.01 Long-term follow-up in patient

✍ U. Schara; H. Christen; M. Hietala; Z. Hoovey; K. Krabetz; C. Rodolico; G. Schre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Clinical features of congenital myasthen

✍ Finlayson, S.; Palace, J.; Belaya, K.; Walls, T. J.; Norwood, F.; Burke, G.; Hol 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 374 KB

Clinical variability of CMS-EA (congenit

✍ N. Barisic; J.S. Müller; E. Paucic-Kirincic; M. Gazdik; K. Lah-Tomulic; A. Pertl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 163 KB